PRISMAP Call for Projects

The PRISMAP consortium has launched its first call for user projects, looking for your applications until March 31, 2022. Follow the submission guidelines, complete the application form and upload your project description to the online platform. Awardees will receive access to PRISMAP’s production and medical facilities and the currently available radionuclides.

PRISMAP is the European medical radionuclide programme on the production of high purity radionuclides and brings together a consortium of 23 beneficiaries from 13 countries, one European Research Laboratory and an International Organisation. PRISMAP offers a single-entry point to researchers who are seeking innovative radionuclides of high purity grade for medical application to enable and accelerate early phase research on radiopharmaceuticals, targeted drugs for cancer, theranostics and personalised medicine.

This website uses cookies. Learn more